XML 67 R60.htm IDEA: XBRL DOCUMENT v3.25.3
Net Income (Loss) Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders - Computation of the Basic and Diluted Net (Income) Loss Per Share Attributable to Common Shareholders (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Earnings Per Share [Abstract]        
Net Income (Loss) $ 9,546 $ (32,071) $ (45,920) $ (125,800)
Weighted-average shares outstanding - basic 152,432,307 147,516,398 151,248,398 146,908,234
Incremental shares attributable to share-based compensation plans 10,729,800      
Weighted-average shares outstanding - diluted 163,162,107 147,516,398 151,248,398 146,908,234
Net income (loss) per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic $ 0.06 $ (0.22) $ (0.3) $ (0.86)
Net income (loss) per share attributable to Adaptive Biotechnologies Corporation common shareholders, diluted $ 0.06 $ (0.22) $ (0.3) $ (0.86)